102 related articles for article (PubMed ID: 32130965)
1. A 27-Year-Old Primigravida with a Right Renal Cell Carcinoma Removed at 30 Weeks of Gestation by Robot-Assisted Retroperitoneoscopic Partial Nephrectomy.
Völler M; Mahmud W; Vallo S; Grabbert M; John P; Khoder WY
Am J Case Rep; 2021 Apr; 22():e927164. PubMed ID: 33866322
[TBL] [Abstract][Full Text] [Related]
2. [Not Available].
Azawi N; Holm M; Henriksen JR; Møller AKH; Lund L
Ugeskr Laeger; 2023 Apr; 185(14):. PubMed ID: 37057700
[TBL] [Abstract][Full Text] [Related]
3. Isolated soft tissue mass of the finger as the first presentation of oligometastatic renal cell carcinoma.
Hopkins DT; Waters D; Manecksha RP; Lynch TH
BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35580945
[TBL] [Abstract][Full Text] [Related]
4. Long-term management of bilateral, multifocal, recurrent renal carcinoma.
Bratslavsky G; Linehan WM
Nat Rev Urol; 2010 May; 7(5):267-75. PubMed ID: 20448660
[TBL] [Abstract][Full Text] [Related]
5. [Robot-assisted left-side partial nephrectomy with a segmental resection of left lower ureter and Boari reconstruction].
Kurbanov AA; Kryukov SR; Chernov DV; Votyakov AY; Shpot EV
Urologiia; 2023 Sep; (4):125-128. PubMed ID: 37850292
[TBL] [Abstract][Full Text] [Related]
6. WITHDRAWN: Surgical management of localised renal cell carcinoma.
Nabi G; Cleves A; Shelley M
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD006579. PubMed ID: 26945259
[TBL] [Abstract][Full Text] [Related]
7. Positive surgical margins in nephron-sparing surgery: risk factors and therapeutic consequences.
Steinestel J; Steffens S; Steinestel K; Schrader AJ
World J Surg Oncol; 2014 Aug; 12():252. PubMed ID: 25103683
[TBL] [Abstract][Full Text] [Related]
8. Definitions and unmet needs in the management of oligomestatic renal cell carcinoma in the modern era.
Francolini G; Campi R; Ciccarese C;
Curr Opin Urol; 2024 Jul; 34(4):300-306. PubMed ID: 38595192
[TBL] [Abstract][Full Text] [Related]
9. Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG).
Soares A; Monteiro FSM; Maluf FC; Bastos DA; Jardim DL; Sasse AD; Gonçalves E Silva A; Fay AP; da Rosa DAR; Wierman E; Kater F; Schutz FA; de Oliveira FNG; Morbeck IAP; Rinck JA; da Trindade KM; Maia MC; Souza VC; da Silva Neto DCV; de Almeida E Paula F; Korkes F; Carvalhal GF; Nogueira L; de Carvalho Fernandes R; Dos Reis RB; Matheus WE; Busato WFS; da Costa WH; de Cássio Zequi S
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1829-1845. PubMed ID: 32410064
[TBL] [Abstract][Full Text] [Related]
10. Surgical metastasectomy for metastatic renal cell carcinoma in the era of targeted and immune therapy: a narrative review.
Tayeh GA; Alkassis M; De La Taille A; Vordos D; Champy CM; Pelegrin T; Ingels A
World J Urol; 2024 Jan; 42(1):51. PubMed ID: 38244094
[TBL] [Abstract][Full Text] [Related]
11. Thermo-ablation of Renal Allograft Tumors: Every Patient, and Every Nephron, Counts.
Altshuler PJ
Transplantation; 2024 Feb; 108(2):333-334. PubMed ID: 37726885
[No Abstract] [Full Text] [Related]
12. ASO Author Reflections: Microwave Ablation-Assisted Clampless and Sutureless Technique for Renal Hilar Tumors.
Chen Y
Ann Surg Oncol; 2024 Jan; 31(1):690. PubMed ID: 37792203
[No Abstract] [Full Text] [Related]
13. Design of a renal-sparing antifungal.
Allison SJ
Nat Rev Nephrol; 2024 Mar; 20(3):155. PubMed ID: 38291106
[No Abstract] [Full Text] [Related]
14. Time trends in surgical provision and cancer-specific outcomes in patients with stage T2-3 kidney cancer: a SEER-based study.
Song Z; Xing J; Sun Z; Kang X; Li H; Ren G; Wang Y
Front Surg; 2024; 11():1370702. PubMed ID: 38742149
[TBL] [Abstract][Full Text] [Related]
15. Preclinical optimization of a diode laser-based clamp-free partial nephrectomy in a large animal model.
Andrade WS; Tang FHF; Mariotti ACH; Mancini MW; Duarte IX; Singer EA; Weiss RE; Pasqualini R; Arap W; Arap MA
Sci Rep; 2023 Jun; 13(1):9237. PubMed ID: 37286592
[TBL] [Abstract][Full Text] [Related]
16. Choice of Surgical Options in Kidney Cancer and Surgical Complications.
Wasserman M; Sobel D; Pareek G
Semin Nephrol; 2020 Jan; 40(1):42-48. PubMed ID: 32130965
[TBL] [Abstract][Full Text] [Related]
17. A robotic-assisted laparoscopic approach for pediatric renal cell carcinoma allows for both nephron-sparing surgery and extended lymph node dissection.
Cost NG; Geller JI; DeFoor WR; Wagner LM; Noh PH
J Pediatr Surg; 2012 Oct; 47(10):1946-50. PubMed ID: 23084214
[TBL] [Abstract][Full Text] [Related]
18. Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting.
Long JA; Bernhard JC; Bigot P; Lanchon C; Paparel P; Rioux-Leclercq N; Albiges L; Bodin T; Nouhaud FX; Boissier R; Gimel P; Méjean A; Masson-Lecomte A; Grenier N; Cornelis F; Grassano Y; Comat V; Le Clerc QC; Rigaud J; Salomon L; Descotes JL; Sengel C; Roupret M; Verhoest G; Ouzaid I; Arnoux V; Bensalah K;
World J Urol; 2017 Apr; 35(4):649-656. PubMed ID: 27498139
[TBL] [Abstract][Full Text] [Related]
19. [Nephron-sparing treatments for kidney cancer].
Casuscelli J; Fischereder M; Gratzke C; Staehler M; Stief CG
MMW Fortschr Med; 2012 Dec; 154(22):45-6, 48. PubMed ID: 23297539
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
